Creatine and Alzheimer’s Disease: Benefits, Evidence, and What the First Human Trial Found
Creatine is being studied as a potential way to support brain energy metabolism in Alzheimer’s disease, but it is not an established Alzheimer’s treatment. The first human pilot study specifically involving people with Alzheimer’s disease was published in 2025. After eight weeks of high-dose creatine monohydrate supplementation, researchers measured higher brain creatine concentrations and improvements on several cognitive tests.
Those findings are interesting, but they are preliminary. The study included only 20 participants, lasted eight weeks, and had no placebo or untreated control group. That means we cannot determine whether creatine caused the cognitive changes, whether the effect would persist, or whether supplementation slows progression of Alzheimer’s disease.
Forge Verdict: Creatine has moved from a plausible Alzheimer’s hypothesis to an early human research question worth following. That is meaningful progress—but not enough evidence to recommend high-dose creatine as an Alzheimer’s therapy. People with Alzheimer’s disease should not copy the 20-gram research dose without discussing it with the clinicians managing their care.
Promising but Preliminary
The first Alzheimer’s creatine pilot involved only 20 participants and did not include a placebo or control group.
It Increased
Eight weeks of supplementation was associated with an approximately 11% increase in brain total creatine measured by magnetic resonance spectroscopy.
Still Experimental
No randomized controlled trial has yet established creatine as an effective treatment for Alzheimer’s disease.
Inside This Guide
- Can creatine help Alzheimer’s disease?
- Why researchers are studying creatine
- Creatine and brain energy metabolism
- What the first human trial found
- Why the study does not prove efficacy
- What the 2026 follow-up added
- Potential muscle and physical benefits
- Creatine and cognition outside Alzheimer’s
- What animal research tells us
- How much creatine did the study use?
- Is high-dose creatine safe?
- Where creatine fits with Alzheimer’s treatment
- Why exercise still matters
- Claims that go beyond the evidence
- Frequently asked questions
Can Creatine Help Alzheimer’s Disease?
We do not know yet.
The biological rationale is credible enough to study. Alzheimer’s disease involves profound changes in brain function, including disruption of normal cellular energy metabolism. Creatine and phosphocreatine help cells buffer and regenerate ATP, the energy currency used throughout the body.
That gives researchers a reasonable hypothesis: if brain creatine availability can be increased, perhaps the brain will be better able to manage some of the energetic stress associated with Alzheimer’s disease.
The important word is perhaps.
The first human data are encouraging enough to justify larger randomized trials. They are not strong enough to conclude that creatine improves Alzheimer’s disease, prevents dementia, reverses memory loss, removes amyloid, alters tau pathology, or slows neurodegeneration.
Interesting evidence and proven treatment are not the same thing.
The 2025 Alzheimer’s pilot moved creatine research forward because investigators showed that supplementation was feasible and that brain creatine could be increased. The study was designed primarily to establish feasibility and generate data for future trials—not to prove clinical efficacy.
Why Are Researchers Studying Creatine for Alzheimer’s Disease?
Creatine is best known for helping skeletal muscle rapidly regenerate ATP during demanding exercise. The brain also uses the creatine-phosphocreatine energy-buffering system.
Neurons require a constant supply of energy to maintain electrical signaling, neurotransmission, ion gradients, cellular repair, and other functions. When energy production becomes impaired, brain cells may be less capable of meeting those demands.
Altered cerebral metabolism is one feature of Alzheimer’s disease, which is why bioenergetics has become one area of therapeutic research.
ATP Buffering
Phosphocreatine can donate a phosphate group to ADP, helping regenerate ATP when cellular energy demand rises.
Brain Creatine Availability
Researchers are examining whether increasing brain creatine can improve the brain's capacity to buffer energy demand.
Mitochondrial Function
Creatine is being studied in relation to mitochondrial and cellular-energy pathways that may be disrupted in neurodegenerative disease.
Physical Function
Creatine may also have value through skeletal muscle, strength, and functional capacity—separate from any direct cognitive effect.
How Creatine Supports Energy in the Brain
Creatine participates in a reversible energy-buffering reaction involving creatine kinase, phosphocreatine, ATP, and ADP.
When energy demand increases, phosphocreatine can transfer a phosphate group to ADP to regenerate ATP. When energy availability is greater, ATP can be used to restore phosphocreatine.
ATP releases energy and becomes ADP as neurons and other cells perform work.
Stored phosphocreatine can rapidly transfer phosphate back to ADP.
When energy supply allows it, the creatine-phosphocreatine pool can be replenished for future demand.
This mechanism is well established physiology. What remains uncertain is whether increasing that system through supplementation changes the clinical course of Alzheimer’s disease.
What Did the First Human Creatine Trial in Alzheimer’s Disease Find?
In 2025, researchers published results from the Creatine to Augment Bioenergetics in Alzheimer’s, or CABA, pilot trial.
The study enrolled 20 people with Alzheimer’s disease. Participants took 20 grams of creatine monohydrate per day for eight weeks.
This was a small feasibility study rather than a large efficacy trial.
The study provides short-term data only.
The research dose was substantially higher than the common 3–5 gram daily dose used for sports supplementation.
Brain total creatine increased when measured with magnetic resonance spectroscopy.
Cognitive testing also changed
Researchers reported improvement from baseline on several measures from the NIH Toolbox cognition battery, including global and fluid cognition composites and selected individual tests.
That finding is encouraging because increasing brain creatine would be far less interesting if there were no measurable functional signal at all.
But the cognitive results have to be interpreted through the design of the study.
Why This Study Does Not Prove Creatine Treats Alzheimer’s
The CABA trial had no placebo group and no untreated comparison group. Everyone received creatine.
That creates several possible explanations for improvement besides the supplement itself.
Association is not yet efficacy.
We can accurately say that creatine supplementation was associated with higher brain creatine and improved scores on several cognitive measures. We cannot yet say creatine caused those cognitive improvements or slowed Alzheimer’s progression.
What Did the 2026 Follow-Up Research Add?
In February 2026, researchers published a second analysis using bioenergetic data from the same CABA pilot cohort.
The purpose was to look more closely at markers related to cellular energy metabolism and mitochondrial function after creatine supplementation.
This is useful mechanistic work because it helps researchers understand what might be happening biologically and which measurements deserve attention in future studies.
It is important not to count that publication as an independent second clinical trial. It comes from the same small, uncontrolled intervention.
The evidence base is growing in depth—not yet in clinical certainty.
Multiple papers can emerge from one trial because researchers analyze different outcomes. What the field still needs most is replication in larger randomized, placebo-controlled studies.
Creatine May Also Matter for Muscle and Physical Function
A separate 2025 analysis of the same pilot study examined skeletal-muscle outcomes and reported modest improvements in selected measures of muscle size and strength after eight weeks of supplementation.
Again, the study had no control group, so those findings remain preliminary.
The physical side of this research is important because Alzheimer's disease affects more than memory. Maintaining strength, muscle mass, mobility, and the ability to perform daily tasks becomes increasingly important as people age and as neurological disease progresses.
Creatine already has a much stronger evidence base for supporting resistance-training performance and muscular adaptation in adults than it does for treating Alzheimer’s disease.
That creates an important distinction:
Creatine for Muscle
There is substantial research supporting creatine monohydrate as a useful supplement for strength and resistance-training outcomes in appropriate adults.
Creatine for Alzheimer’s Disease
The evidence remains preliminary and experimental, with no controlled efficacy trial yet establishing a therapeutic benefit.
For the larger supplement evidence, see Creatine: Does It Work, Is It Safe, and Should You Take It?
What Does Research Say About Creatine and Cognition More Broadly?
Creatine has been studied for cognitive performance in people without Alzheimer’s disease for considerably longer than it has been studied in diagnosed Alzheimer’s patients.
A 2024 systematic review and meta-analysis of randomized trials found possible benefits in several cognitive domains, including memory and information-processing measures. Other reviews have found that effects are more apparent in some populations than others.
Potentially responsive groups have included older adults, people with low dietary creatine intake, and people under acute metabolic or cognitive stress such as sleep deprivation.
That does not mean improvements in cognition among healthy or sleep-deprived adults can simply be extrapolated to Alzheimer’s disease.
“Creatine may support cognition” is not the same claim as “creatine treats dementia.”
Different populations, diseases, doses, outcomes, and study designs answer different scientific questions.
What Have Animal and Laboratory Studies Shown?
Before the first human Alzheimer’s pilot was performed, much of the interest in creatine came from preclinical research and mechanistic reasoning.
Animal models and cellular studies have explored whether creatine can influence energy metabolism, oxidative stress, mitochondrial function, neuronal signaling, and Alzheimer’s-related pathology.
Some findings have been encouraging enough to justify human studies.
Preclinical evidence is valuable for deciding what to test next. It is not clinical proof.
Many interventions that produce impressive results in rodents or isolated cells fail when studied in humans because Alzheimer’s disease is vastly more complex than a laboratory model.
How Much Creatine Was Used in the Alzheimer’s Study?
The CABA pilot used 20 grams of creatine monohydrate per day for eight weeks.
That dose is important because it is much higher than the amount typically used for long-term sports or strength supplementation.
The investigators used a high dose partly because increasing creatine in the brain appears more difficult than increasing creatine in skeletal muscle.
That does not mean 20 grams per day should now be considered the recommended Alzheimer’s dose.
Do not copy a pilot-trial dose as a self-treatment protocol.
The appropriate dose for cognitive or Alzheimer’s-related use has not been established. Older adults may also have kidney disease, cardiovascular disease, diabetes, medication interactions, swallowing difficulties, dehydration risk, or other medical factors that deserve clinician review before high-dose supplementation.
Is Creatine Safe for People With Alzheimer’s Disease?
Creatine monohydrate has an extensive general safety record in healthy adults, but that evidence should not be automatically extended to every older adult with Alzheimer’s disease at a 20-gram daily dose.
The 2025 Alzheimer’s pilot demonstrated that eight weeks of high-dose supplementation was feasible in that small group. That is reassuring but does not establish long-term safety for the larger Alzheimer’s population.
Older adults may have health considerations that make supplementation less straightforward.
Kidney Function
Known kidney disease or unexplained abnormal kidney testing deserves medical review before supplementation. Creatine can also increase serum creatinine without necessarily representing kidney injury, which can complicate interpretation of laboratory results.
Medication and Medical History
A physician or pharmacist should consider medications, cardiovascular health, diabetes, hydration, and other conditions relevant to the individual.
Gastrointestinal Tolerance
Larger creatine doses can be harder to tolerate and may cause gastrointestinal discomfort in some people.
Caregiver Oversight
Cognitive impairment may make independent supplement dosing unreliable, which is another reason to involve the medical team and caregiver when appropriate.
Creatine Is Not a Replacement for Alzheimer’s Medical Treatment
The treatment landscape for Alzheimer’s disease has changed substantially.
Care can include medications aimed at symptoms as well as disease-modifying anti-amyloid therapies for selected people with early Alzheimer’s disease and confirmed amyloid pathology.
Creatine has not been shown to replace, match, or enhance those treatments.
No one should discontinue prescribed Alzheimer’s medication, delay a neurological evaluation, or substitute a supplement for an evidence-based treatment plan because of the early creatine findings.
Creatine remains investigational for Alzheimer’s disease.
Decisions about diagnosis, anti-amyloid therapy, medication, imaging, genetic considerations, biomarkers, and clinical-trial participation belong with the physicians and specialists managing the disease.
Where Exercise and Strength Training Fit
One reason creatine is particularly interesting to the fitness field is that its potential brain effects are being studied alongside a well-established role in skeletal-muscle energy metabolism.
For older adults, maintaining physical capacity matters independently of whether creatine ever becomes an Alzheimer’s therapy.
Walking and other appropriate aerobic activity support cardiovascular health, mobility, and daily function.
Appropriately supervised strength training helps maintain muscle, strength, balance, and the physical capacity needed for daily tasks.
Protein, total energy, hydration, and nutrient intake become especially important when appetite, body weight, or physical function declines.
Exercise should account for neurological status, cardiovascular health, fall risk, medications, balance, cognition, and the person's current abilities.
Creatine could eventually prove useful as an additional tool within that larger picture. It should not distract from the fundamentals that already have a strong reason to be there.
See our guide to longevity-focused training for a broader look at strength, aerobic fitness, mobility, balance, and healthy aging.
Creatine and Alzheimer’s Claims That Go Beyond the Evidence
Hope Without Turning Preliminary Science Into Hype
The creatine-Alzheimer’s story is more interesting today than it was only a few years ago.
Researchers now have human evidence that a high-dose creatine intervention can increase creatine inside the brains of people with Alzheimer’s disease. They also observed improvements on several cognitive measures and generated additional muscle and bioenergetic data worth investigating.
That is legitimate scientific progress.
The next step is not to declare that creatine treats dementia. It is to conduct larger randomized, placebo-controlled trials that can answer the questions the pilot was never designed to settle.
This is exactly where I think fitness and nutrition professionals need to resist getting ahead of the evidence. I am very positive about creatine when the research supports its use for strength and training. Alzheimer’s is different. The new data are genuinely interesting, but “interesting enough to study” and “proven enough to prescribe” are two very different standards.
Frequently Asked Questions About Creatine and Alzheimer’s Disease
Does creatine help people with Alzheimer’s disease?
We do not know yet. A 2025 single-arm pilot found increased brain creatine and improvements on several cognitive measures after eight weeks, but there was no placebo group. Larger controlled trials are required before efficacy can be established.
Has creatine been clinically tested in Alzheimer’s patients?
Yes. The first published human Alzheimer’s creatine pilot appeared in 2025. Twenty participants received 20 grams of creatine monohydrate daily for eight weeks.
How much did brain creatine increase in the study?
The researchers reported an approximately 11% increase in brain total creatine measured using magnetic resonance spectroscopy.
Did creatine improve memory in Alzheimer’s disease?
Participants improved on several cognitive measures, but the study design cannot establish that creatine caused those improvements. Practice effects, natural variation, and other factors cannot be separated from a true treatment effect without a control group.
Does creatine prevent dementia?
No clinical evidence currently establishes creatine supplementation as a dementia-prevention strategy.
Can creatine reverse Alzheimer’s disease?
No. There is no evidence that creatine reverses Alzheimer’s disease.
Does creatine remove amyloid plaques?
That has not been established in humans. Creatine should not be confused with anti-amyloid medications specifically developed and clinically tested to affect amyloid pathology.
Why might creatine affect the brain?
The brain uses the creatine-phosphocreatine system to help buffer cellular energy and regenerate ATP. Researchers are investigating whether increasing brain creatine can support energy metabolism under neurological stress.
Can creatine cross the blood-brain barrier?
Brain creatine can increase after supplementation, although the response is more limited than the increase typically seen in skeletal muscle. The 2025 Alzheimer’s pilot directly demonstrated a measurable increase in brain total creatine.
Should someone with Alzheimer’s take 20 grams of creatine every day?
Not based solely on the pilot study. Twenty grams per day was an experimental research dose, not an established treatment recommendation. The decision should be discussed with the clinicians managing the person's Alzheimer’s disease and overall medical care.
Is 5 grams of creatine enough for brain health?
No specific dose has been established for preventing or treating cognitive decline. Five grams per day is commonly used for skeletal-muscle supplementation, but brain and Alzheimer’s research has often investigated different and sometimes much larger doses.
Is creatine safe for older adults?
Creatine monohydrate has a strong general safety record, including research in older adults. Individual medical conditions, kidney function, medications, hydration, and the much larger doses used in some brain studies still deserve clinician review.
Can creatine damage the kidneys?
Standard supplementation has not been shown to reduce kidney filtration in healthy adults. People with known kidney disease or abnormal kidney testing should obtain medical guidance, and clinicians should know about creatine use when interpreting serum creatinine results.
Is creatine an FDA-approved treatment for Alzheimer’s?
No. Creatine is not an FDA-approved Alzheimer’s treatment.
Can creatine be taken with Alzheimer’s medications?
That decision should be individualized. A physician or pharmacist should review the person's complete medication list, kidney function, medical conditions, hydration status, and supplement dose rather than assuming every combination is appropriate.
Does creatine improve cognition in healthy older adults?
Some research suggests potential benefits for memory and selected cognitive outcomes, particularly in older adults and other populations under greater metabolic stress. The evidence is less established than creatine's effects on strength and exercise performance.
What research needs to happen next?
The most important next step is larger randomized, placebo-controlled research that examines cognition, function, disease biomarkers, safety, optimal dose, duration, and whether any benefits persist over clinically meaningful periods.
Strength and Healthy Aging Still Start With the Fundamentals
Forge helps adults build personalized strength, nutrition, aerobic fitness, mobility, and sustainable habits around their current abilities and health considerations. We do not diagnose or treat Alzheimer’s disease, but appropriately designed exercise and nutrition can remain important parts of maintaining physical capacity as people age.
Evidence & Further Reading
- Smith AN, et al. Creatine Monohydrate Pilot in Alzheimer’s: Feasibility, Brain Creatine, and Cognition. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2025.
- Taylor MK, et al. Bioenergetic Data From a Creatine Monohydrate Pilot Trial in Alzheimer’s Disease. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2026.
- Smith AN, et al. Eight Weeks of Creatine Monohydrate Supplementation Is Associated With Increased Muscle Strength and Size in Alzheimer’s Disease: Data From a Single-Arm Pilot Study. Frontiers in Nutrition. 2025.
- Xu C, et al. The Effects of Creatine Supplementation on Cognitive Function in Adults: A Systematic Review and Meta-Analysis. Frontiers in Nutrition. 2024.
- Prokopidis K, et al. Effects of Creatine Supplementation on Memory in Healthy Individuals: A Systematic Review and Meta-Analysis. Nutrition Reviews. 2023.
- Roschel H, et al. Creatine Supplementation and Brain Health. Nutrients. 2021.
- ClinicalTrials.gov. Creatine to Augment Bioenergetics in Alzheimer’s Disease — CABA. NCT05383833.
- U.S. Food and Drug Administration. Traditional Approval of Lecanemab for Alzheimer’s Disease.
- U.S. Food and Drug Administration. Approval of Donanemab for Alzheimer’s Disease.
Medical disclaimer: Alzheimer’s disease is a progressive neurological disorder requiring medical diagnosis and management. This article provides general education and does not recommend creatine as a treatment or preventive therapy for Alzheimer’s disease. Do not begin high-dose creatine, discontinue prescribed medication, alter Alzheimer’s treatment, or delay neurological evaluation based on this article. People with Alzheimer’s disease or cognitive impairment should discuss supplements with the physicians and pharmacists managing their care, particularly when kidney disease, diabetes, cardiovascular disease, dehydration, swallowing difficulty, or multiple medications are present.


